Insiders · Profile

Beskrovnaya Oxana

Chief Scientific Officer at Dyne Therapeutics. Filing since 20 Sep 2021. CIK 0001824542

Company
Date
Role
Action
Shares
Amount
Of holding
11 Mar 2025
Chief Scientific Officer
Sold on a plan
2,153
$24.50K
1.1%
5 Mar 2025
Chief Scientific Officer
Sold on a plan
1,094
$12.94K
0.5%
18 Feb 2025
Chief Scientific Officer
Sold on a plan
2,598
$36.24K
1.3%
11 Dec 2024
Chief Scientific Officer
Sold on a plan
2,334
$65.63K
1.1%
18 Nov 2024
Chief Scientific Officer
Sold on a plan
2,856
$80.54K
2.0%
18 Sep 2024
Chief Scientific Officer
Sold on a plan
2,339
$80.81K
1.6%
11 Sep 2024
Chief Scientific Officer
Sold on a plan
2,161
$68.91K
1.5%
19 Aug 2024
Chief Scientific Officer
Sold on a plan
2,636
$118.94K
1.8%
11 Jun 2024
Chief Scientific Officer
Sold at will
2,136
$66.94K
1.4%
20 May 2024
Chief Scientific Officer
Sold on a plan
30,426
$1.00M
16.9%
16 May 2024
Chief Scientific Officer
Sold on a plan
2,705
$76.47K
1.8%
11 Mar 2024
Chief Scientific Officer
Sold on a plan
2,081
$53.48K
1.3%
7 Mar 2024
Chief Scientific Officer
Sold on a plan
2,373
$61.34K
1.5%
4 Jan 2024
Chief Scientific Officer
Sold on a plan
42,453
$769.67K
21.3%
3 Jan 2024
Chief Scientific Officer
Sold on a plan
45,326
$860.31K
20.4%
11 Dec 2023
Chief Scientific Officer
Sold at will
1,467
$15.73K
0.8%
18 Sep 2023
Chief Scientific Officer
Sold at will
1,436
$13.51K
1.7%
12 Sep 2023
Chief Scientific Officer
Sold at will
1,484
$15.45K
1.7%
13 Jun 2023
Chief Scientific Officer
Sold at will
1,475
$18.33K
1.7%
14 Mar 2023
Chief Scientific Officer
Sold, plan not stated
1,416
$18.88K
1.6%
12 Dec 2022
Chief Scientific Officer
Sold, plan not stated
680
$7.39K
0.7%
11 Mar 2022
Chief Scientific Officer
Sold, plan not stated
693
$6.05K
1.3%
21 Sep 2021
Chief Scientific Officer
Sold, plan not stated
827
$13.32K
4.4%
20 Sep 2021
Chief Scientific Officer
Sold, plan not stated
617
$9.63K
3.2%
24 decisions on file.